2226 - 2250 of 8142 Results
Title
Year
- A novel risk calculator predicting surgical site infection after spinal surgery in patients with cerebral palsy2022RESTRICTEDTitle: A novel risk calculator predicting surgical site infection after spinal surgery in patients with cerebral palsyJournal Name: Developmental Medicine & Child NeurologyPublisher: WileyVol: 64Issue #: 8Start Page: 1034End Page: 1043Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/dmcn.15193Citation Count: 2
-
RESTRICTEDTitle: The Disease Modification Conundrum in Parkinson’s Disease: Failures and HopesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.810860Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.810860/pdfCitation Count: 22
- NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation2022OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 5
-
OPENTitle: A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1088End Page: 1093Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28970Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28970Citation Count: 24
- Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain Stimulation2022OPENTitle: Additive Effect of Dopaminergic Medication on Gait Under Single and Dual-Tasking Is Greater Than of Deep Brain Stimulation in Advanced Parkinson Disease With Long-Duration Deep Brain StimulationJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 364End Page: 373Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.015Citation Count: 3
-
RESTRICTEDTitle: Physician‐Assisted Dying: Access and Utilization in Patients with Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 694End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28964Citation Count: 2
- Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale2022RESTRICTEDTitle: Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 826End Page: 841Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28905Citation Count: 5
- CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers2022OPENTitle: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834580Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.834580/pdfCitation Count: 24
-
RESTRICTEDTitle: Etiology, pathological characteristics, and clinical management of black pleural effusionJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 8Start Page: e28130End Page: e28130Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/md.0000000000028130Best OA location URL: https://doi.org/10.1097/md.0000000000028130Citation Count: 6
-
OPENTitle: Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2112712119Best OA location URL: https://doi.org/10.1073/pnas.2112712119Citation Count: 41
-
RESTRICTEDTitle: Slowing Parkinson’s Disease Progression with Vaccination and Other ImmunotherapiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 36Issue #: 4Start Page: 327End Page: 343Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s40263-022-00903-7Citation Count: 8
-
OPENTitle: Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid AngiopathyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200136Best OA location URL: https://n.neurology.org/content/neurology/98/17/e1716.full.pdfCitation Count: 26
- Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease2022OPENTitle: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 26Issue #: 2Start Page: 320End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017Best OA location URL: http://www.neuromodulationjournal.org/article/S1094715922000381/pdfCitation Count: 42
- Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes2022OPENTitle: Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 167Issue #:Start Page: 105668End Page: 105668Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105668Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105668Citation Count: 20
-
OPENTitle: Defining Utility Values for Chorea Health States in Patients with Huntington’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 4Start Page: 1784End Page: 1793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02046-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02046-z.pdfCitation Count: 3
- Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads2022OPENTitle: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beadsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.73971Best OA location URL: https://doi.org/10.7554/elife.73971Citation Count: 53
- Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study2022OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 9
- Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease2022OPENTitle: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00520-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-022-00520-4Citation Count: 15
-
RESTRICTEDTitle: Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 6Start Page: 847End Page: 847Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00110Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00110Citation Count: 0
- Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study2022OPENTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 15
-
OPENTitle: Disruption of Mitochondrial Complex I Induces Progressive ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 478End Page: 478Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28961Best OA location URL: https://doi.org/10.1002/mds.28961Citation Count: 11
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains2022OPENTitle: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e3001427End Page: e3001427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001427Best OA location URL: https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001427&type=printableCitation Count: 22
- Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses2022OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 1
-
RESTRICTEDTitle: Prodromal Parkinson's disease: hype or hope for disease-modification trials?Journal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-022-00286-1Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-022-00286-1Citation Count: 26
- Qigong Training Positively Impacts Both Posture and Mood in Breast Cancer Survivors With Persistent Post-surgical Pain: Support for an Embodied Cognition Paradigm2022OPENTitle: Qigong Training Positively Impacts Both Posture and Mood in Breast Cancer Survivors With Persistent Post-surgical Pain: Support for an Embodied Cognition ParadigmJournal Name: Frontiers in PsychologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyg.2022.800727Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyg.2022.800727/pdfCitation Count: 10